Market Currents
Transcept Pharmaceuticals (TSPT) says that on February 21 it received a new Paragraph IV notice...
-
Monday, February 25, 4:39 PM ETTranscept Pharmaceuticals (TSPT) says that on February 21 it received a new Paragraph IV notice letter from Dr. Reddy's Laboratories (RDY) advising that it's filed an Abbreviated New Drug Application with the FDA for generic versions of Intermezzo.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
